688198 佰仁医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)7.42111.95910.0359.0995.606
总资产报酬率 ROA (%)6.35010.6129.1918.6055.383
投入资产回报率 ROIC (%)6.98411.6469.8859.0375.570

边际利润分析
销售毛利率 (%)88.16588.33989.84589.37588.243
营业利润率 (%)26.49230.52932.59836.39320.892
息税前利润/营业总收入 (%)24.83028.68232.36235.62919.208
净利润/营业总收入 (%)21.77826.33029.51931.98020.357

收益指标分析
经营活动净收益/利润总额(%)80.36492.60083.47279.29164.941
价值变动净收益/利润总额(%)7.2907.13214.89321.01431.953
营业外收支净额/利润总额(%)-6.031-1.614-0.668-1.209-5.735

偿债能力分析
流动比率 (X)3.3005.1708.42911.45123.311
速动比率 (X)2.8914.7087.99610.95322.711
资产负债率 (%)17.09312.59910.4346.8224.145
带息债务/全部投入资本 (%)3.024-2.206-2.432-0.9430.136
股东权益/带息债务 (%)3,019.170-4,401.002-4,017.473-10,542.42872,852.436
股东权益/负债合计 (%)489.586694.817862.7531,368.3902,315.807
利息保障倍数 (X)-160.635-21.058-1,704.972-108.218-34.876

营运能力分析
应收账款周转天数 (天)91.96173.54068.70559.99148.881
存货周转天数 (天)373.903269.552317.476306.770232.915